In a study of melanoma and NSCLC, 3 patients encountered pseudoprogression during treatment, with imaging findings showing tumor enlargement and a significant decrease in serum IL-8 levels, and serum IL-8 levels remained below baseline when tumor load back to normal. The gene discussed is CXCL8; the disease is neoplasm.